Cytokinetics was founded in August 1997 by cell biology pioneers, leaders in the field of cytoskeletal biology and working to create a powerful approach to drug discovery. Cytokinetics' broad drug discovery platform affords an opportunity for multiple strategic alliances in pharmaceutical discovery, development and commercialization. Cytokinetics is seeking to capitalize on their expertise in cytoskeletal molecular and cellular biology by partnering selectively with biotechnology and pharmaceutical companies for the optimization and development of well-characterized families of pharmaceutical lead compounds.